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Synopsis 
A procedure for the preparation of new block copolymers composed of a hydrophobic block of 
polystyrene, a hydrophilic spacer-block of poly(ethy1ene oxide) and a bioactive block of heparin 
was investigated. Polystyrene with one amino group per chain was synthesized by free radical 
oligomerhtion of styrene in dimethylformamide, using 2-aminoethanethiol as a chain transfer 
agent. This amino group was used in the coupling reaction with amino-telechelic poly(ethy1ene 
oxide) to produce an AB type diblock copolymer with one amino group per polystyrene 
(PSt)-poly(ethy1ene oxide) (PEO) chain. The amino-semitelechelic oligestyrene was converted 
into the isocyanatrsemitelechelic oligo-styrene using toluene 2,4diisocyanate and subsequent 
coupling with H,N-PEO-NH, afforded AB type block copolymers with terminal amino groups. 
The coupling of PSt-PEO-NH, with heparin was performed in a DMF-H,O mixture, first by 
activating the heparin carboxylic groups with EDC at pH 5.1-52 and subaequently reading the 
activated carboxylic groups with the amino groups of the PSt-PEO-NH2 at pH 7.5. Depending 
on the molecular weights of the diblock copolymer used 25-29% w/w heparin was incorporated. 
Thew polymers will be further evaluated for their blood-compatibility. 
INTRODUCTION 
The extent of thrombus formation at blood-polymer interfaces in blood- 
contacting devices, such as cardiovascular prostheses and catheters, can be 
Illllllllllzed by utilizing nonthrombogenic polymem or nonthrombogenic poly- 
meric coatings. 
Enhancement of the blood-compatibility of materials can be achieved by 
modification of the surface without altering the bulk properties. An example is 
the treatment of material surfaces by plasma polymerization of tetra- 
fluoroethylene (TFE). Mylar, poly(ethy1ene teraphthalate) surfaces covered 
coagulation times (using Lindholm's test) as compared to bare Mylar surfaces.2 
Another approach was followed by Horbett and ~o-workers,~ who found 
that hydrogel-grafted surfaces adsorbed less protein and adhered blood cells 
less strongly than ungrafted hydrophobic substrate polymers. This was hy- 
pothesized to be due to the low interfacial tension exhibited between a 
hydrogel surface and blood. Mori and co-workers4 reported studies on 
poly(ethy1ene oxide) (PEO) chains grafted onto surfam. It was shown that 
the number of adhered platelets and the amount of adsorbed plasma proteins 
mghificantly decreased with an increase in the PEO chain length (n) ,  with a 
maximum value at  n = 100 (water content 404%). 
. .  . 
by thin plasma-polymerized 6 l m ~  of TFE showed si@cantly increased blood 
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A different method to improve the blood-compatibility of polymeric sur- 
faces is to immobilize bioactive agents onto a polymer surface through the use 
of a spacer. Heparin, the most commonly used anticoagulant, has been 
covalently coupled to hydroxyl-bearing surfaces via an ethylene h i d e  inter- 
mediate,5 ionically-bound to polyethylene surfaces by prior adsorption of a 
cationic surfactant,6 immobilized on a variety of cyanogen bromide-activated 
surfaces,7 and recently immobilized via carboxylic groups to diaminoalkane 
agarose gels? Heparin directly affixed to the surface does not provide optimal, 
solution-like anticoagulant behavior, but anticoagulant activity increases 
precipitously for 10-carbon unit spacer groups and longer, while heparin 
coupled with less than 10-carbon spacer groups demonstrates only minimal 
anticoagulant activity.’ This concept was applied to polyurethane surfaces 
and improved the blood-compatibility of cathetern positioned in the external 
jugular and femoral veins in the direction of the blood flow in short-term dog 
e~periments.~ 
Block copolymer surfaces that exhibit heterogeneous microphase separated 
surface structures of hydrophilic and hydrophobic microdomains have shown 
an ability-to suppress platelet adhesion’’ and morphological changes of 
adhering platelets.” Because of this heterogeneous microdomain surface 
structure, an “organized protein layer” is hypothesized to be formed after 
contact with blood and is supposed to regulate the distribution of different 
binding sites on a molecular level at  the platelet and polymer interface, 
thereby influencing the adhesion and activation of platelets.12 
We hypothesize that, through the use of an ABC type block copolymer 
consisting of a hydrophobic group (A), a hydrophilic spacer (B), and a 
bioactive agent (C), the blood-compatibility of biomaterials could be im- 
proved. The hydrophobic block can be anchored into a substrate by swelling 
with a proper solvent in a coating process resulting in the exposure of the 
hydrophilic spacer coupled with antithrombotic agents. Then, the block 
copolymer could be coated onto materials so that a coating of heterogeneous 
microphase-separated hydrophobic and hydrophilic microdomains would be 
exhibited. Finally, the block copolymer could be used for fabrication of blood 
contacting devices. 
In this paper the results of the synthesis and characterization of a new 
polystyrene-poly(ethy1ene oxide)-heparin ABC type block copolymer, 
containing polystyrene as hydrophobic block, poly(ethy1ene oxide) as 
hydrophilic spacer-block and covalently bonded heparin as bioactive block, 
are presented. 
EXPERIMENTAL 
Materials 
2-Aminoethanethiol (AESH, Aldrich Chemical Company, Inc., Milwaukee, 
WI), amino-telechelic poly(ethy1ene oxide)s, with molecular weights 500 and 
4000 [H2N-PEO(500 or 4000)-NH,, a generous gift of Nippon Oil & Fats 
Company, Ltd., Ibaraki Japan], 2,2’-azobisisobutyronitrile (AIBN, Polysci- 
ences Inc., Warrington, PA), l-ethy1-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDC, Sigma Chem. Co., St. Louis, MO), heparin (Hep) from 
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porcine mucosa, with a specific activity of 161.9 U/mg, as indicated by the 
manufacturer (Diosynth Inc., Chicago, IL,), tetrahydrofuran (THF) for use in 
high performance liquid chromatography (J. T. Baker B. V., Deventer, Hol- 
land), toluidine blue (Fluka, Buchs, Switzerland), and the solvents chloroform 
(Fisher Scientific Co., Fair Lawn, NJ), ethanol (E. Meck, Darmstadt, 
Germany), ether and hexanes (J. T. Baker Chem. Co., Phillipburg, NJ), 
methanol (Mallinckrodt Inc., Paris, KY), and toluene (E. Merck) were used as 
received. 
N,N-Dimethylformamide (DMF, J. T. Baker Chem. Co.) was distilled under 
nitrogen at reduced pressure, after drying over anhydrous magnesium sulphate 
(100 g/L), and the fraction of bp 65"C/39 mm Hg was used. Dioxane (J. T. 
Baker Chem. Co.) was distilled once. Styrene (St, Polysciences Inc.) was 
distilled under N, at reduced pressure and the fraction of bp 45OC/18 mm Hg 
was collected. Toluene 2,4-diisocyanate (TDI, Eastman Kodak Co., Rochester, 
NY) was distilled under N, at reduced pressure and the fraction of bp 
12O0C/1O mm Hg was used. 
Amino-Semitelechelic Oligo-Styrene ([l], PSt-NH,)13 
PSt-NH, [l] was prepared according to the procedure of Okano and 
~o-workers.'~ DMF solutions containing 2,2'-azobisisobutyronitrile (AIBN, 
5 X mol/L), styrene (St, 5.00 mol/L) and different amounts of 2- 
aminoethanethiol (AESH) as a chain transfer agent were placed into am- 
poules. The ampoules were then i m m d  in liquid N, and evacuated to 
2 X lo-, mm Hg. After warming, clear solutions were obtained. Thee solu- 
tions were subsequently refrozen and the degassing operation was re- 
peated three times. The ampoules were then sealed under reduced pressure at  
2 X lo-, mm Hg. Reactions were carried out by placing the ampoules in a 
shaking water bath, maintaining the temperature at  60°C. 
After the appropriate reaction time the contents of the ampoules were 
poured into methanol to precipitate the PSt-NH, oligomers [l]. The oligomers 
were collected using a sintered-glass funnel, washed several times with 
methanol, and subsequently dried at  reduced pressure. 
Amino-Semitelechelic Polystyrene-Poly(ethy1ene oxide) 
Diblock Copolymer ([5], PSt-PEO-NH,)l2> l4 
PSt-PEO-NH, diblock copolymers [5] were synthesized by a procedure 
analogous to that used to prepare polystyrene-HEMA block copolymers (as 
published by Okano and co-workers12.14). The current procedure involves a 
coupling reaction of the oligomers of isocyanate-semitelechelic oligo-styrene 
([3], PSt-N=C=O) and amino-telechelic poly(ethy1ene oxide) ([4], 
H,N-PEO-NH,). PSt-N=C=O [3] was prepared as follows: PSt-NH, ([l], 
15% w/v in dioxane) was added dropwise to a solution of toluene 2,4-diiso- 
cyanate [2] in dioxane (0.3% v/v) during a period of 120 h until a final ratio of 
[NH,]/[NCO] = 0.5 was obtained. The reaction mixture was kept at 40°C 
under a nitrogen blanket. A sample of PSt-N=C=O [3] was obtained after 
precipitation in hexane, filtration, and drying at reduced pressure. The pres- 
ence of isocyanate groups in PSt-N=C=O [3] was confirmed by IR-spec- 
troscopy. 
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The PSt-PEO-NH, diblock copolymer [S] was synthesized by adding the 
PSt-N=C=O [3] dioxane solution as described above dropwise over a period 
of 72 h to a solution of H,N-PEO-NH, [4] in dioxane (10% w/v) until the 
final ratio of [NH,]/[NCO] groups was 2.4. This reaction was carried out at  
room temperature under a nitrogen atmosphere. The unreacted oligo-styrene 
was removed by pouring the reaction mixture into a 10-fold volume of mixture 
of ether and hexanes (1 : 9, v/v). The precipitated polymer was then a mixture 
of [4] and [S]. To remove unreacted poly(ethy1ene oxide) [4], the precipitate 
was dissolved in dioxane and reprecipitated in a methanol-water mixture 
(1 : 9, v/v). The resulting diblock copolymer was isolated by filtration of the 
reaction mixture using a sintered-glass funnel and dried at reduced pressure. 
PolysQmne-Poly(ethylene oxide)-Heparin Block Copolymer 
([a, PSt-PEO-Hep) 
PSt-PEO-Hep block copolymers [7] were synthesized via a coupling reac- 
tion of PSt-PEO-NH, diblock copolymer [S] with heparin ([S], Hep) using 
l-ethyl-3-(3-dimethy~opropyl)carbodiimide hydr~chloride'~ ( E X )  as a 
coupling agent. Wt-PEO-NH, [S] was dissolved in DMF. Small amounts of 
water were then added until the h a l  ratio of DMF : H,O became 40 : 1 (v/v) 
and the final concentration of [S] was 4.88 g/100 mL. Hep [6] was dissolved in 
water. DMF was added until the final ratio of H,O : DMF was 1 : 40 (v/v) and 
the final concentration of [6] was 2.0 g/L. The two solutions were combined 
and the pH of the resulting solution was adjusted to 5.1-5.2 using a 1N 
hydrochloric acid solution. EDC was dissolved in a DMF-H,O mixture (40 : 1, 
v/v) and eight equal portions of this solution (32.2 g/L) were added to the 
combined solution at 30 min intervals. The pH was maintained at 5.1-5.2 by 
adding a 1N hydrochloric acid solution or a 1N sodium hydroxide solution. 
Thirty minutes after the last addition of EDC, the pH was adjusted to 7.5 
with a 1N sodium hydroxide solution and the r d t i n g  solution was gently 
stirred for 20 h. 
The polymer was precipitated by adding this solution to a 10-fold excess of 
vigorously stirred methanol. The polymer was collected by filtration, suspend- 
ed in water to remove the unreacted Hep and EDC and then in THF to 
remove the unreacted PSt-PEO-NH, [S]. After filtration using a sintered- 
glass funnel the block copolymer was collected and dried at  reduced pressure. 
Spectro-py 
Infrared (IR) spectra of films of the oligomers and block copolymers cast on 
sodium chloride crystals from solutions in either chloroform or dioxane were 
recorded on a Beckman, Microlab 620 MX infrared spectrophotometer. 'H- 
nuclear magnetic resonance (NMFt) spectra were obtained using a JEOL 
JNM-FX 270 apparatus. The oligomers and diblock copolymers were dis- 
solved in chloroform-d, and tetramethylsilane was added as an internal 
standard. 
Molecular Weights 
Number-average molecular weights (an), weight-average molecular weights 
(Bw)-and the molecular weight distributions (gw/gn) of PSt-NH, [l] 
and Mn,app and @w,app of diblock copolymers were determined by high per- 
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formance liquid chromatography/low angle laser light scattering 
(HPLC/LALLS) (waters Model 60oO A HPLC-system, coupled to a Chro- 
matix KMX-6 --detector and a Waters Merential Refractometer R 
401 concentration-detector), using ultra-Styragel columns with exclusion limits 
lo6, lo4, lo3, and 500 A in series. THF was used as a solvent and the flow rate 
was 2.02 mL/min. Refractive index increments (dn/&) were determined by a 
Brice Phoenix differential refractometer. The an of low molecular weight 
samples of PSt-NH, [l] and PSt-PEO-NH, [6] were determined by vapor 
pressure osmometry (VPO) (Hewlett-Packard 301 A) in toluene at 37°C. 
Amino Group Analysis 
End group analysis of amino groups in PSt-NH, [l] and PSt-PEO-NH, 
[6] was carried out by potentiometric titration of polymer solutions in DMF 
with a 0.02N perchloric acid-DMF solution. The perchloric acid solution was 
prepared by dissolving approximately 0.84 mL of 70% perchloric acid (Fluka) 
in 500 mL DMF. This solution was standardized with diphenylguanidine 
(DPG, Janssen Chimica, Beerse, Belgium) dissolved in DMF. 
Heparin Content in Block Copolymers 
The weight percentages of heparin in the Merent PSt-PEO-Hep block 
copolymers [7] were determined according to a slightly modified colorimetric 
assay described by Smith and ~o-workers.~~ This assay has also been used to 
determine the amount of immobilized heparin in heparin-agarose and 
heparin-Sepharose preparations. 
A standard curve for the measurement of heparin content in PSt-PEO-Hep 
[7] was obtained as follows: Glass tubes were cleaned by treatment with 5% 
w/v potassium dichromate in nitric acid. After washing three times with 
double distilled water and two times with methanol the tubes were dried in an 
oven at 120OC. Solutions of toluidine blue C2.5 mL, 50 mg/L DMF-H,O 
(40 : 1, v/v)] were pipetted into clean glass tubes. Then different amounts of a 
standard heparin solution [0.2 g/L DMF-H,O (40 : l)] were added to the 
glass tubes containing the toluidine blue solution, affording a range of 10-70 
pg of heparin per tube. One tube which contained no heparin solution was 
used as a reference. The contents of the tubes were diluted with DMF-H,O 
(40 : 1) to a total volume of 5 mL. The contents were mixed using a Vortex 
mixer for 30 s. Hexanes (5 mL) were then added to each tube and the tubes 
were shaken vigorously for another 30 s. The dye depletion of toluidine blue in 
the DMF-H,O layers was detected in samples which were first diluted with 
absolute ethanol (1 : 5) by measuring the absorbance at  631 nm using a Zeiss 
PM6 spectrophotometer. Absorbances were measured within 60 min after 
mixing the heparin containing agent and the dye. 
The standard curve was obtained by plotting the decrease in absorbance of 
the toluidine blue solution at 631 nm as a function of the amount of heparin 
present. The heparin content in the block copolymers was determined by 
adding three different amounts of a PSt-PEO-Hep solution [0.6 g/L 
DMF-H,O (40 : l)] to tubes containing the toluidine blue solution [2.5 mL, 50 
mg/L DMF-H,O (40: l)]. The same procedure as described for heparin was 
followed. Quantitation of the amount of heparin bound to PSt-PEO-NH, 
diblock copolymers [S] was achieved by monitoring the dye depletion at  631 
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nm in the DMF-H,O layer [which was also previously diluted with absolute 
ethanol (1 : 5)] and comparing the results with the standard curve obtained for 
heparin. 
RESULTS AND DISCUSSION 
Synthesis of Amino-Semitelechelic Oligo-Styrene [l] 
PSt-NH, [l] was synthesized by a free-radical oligomerization of St, using 
AESH as a chain transfer agent.13 Similar radical polymerizations to obtain 
specific end groups were reported by Ikada and co-workerS.18 The reaction 
proceeds according to the conventional telomerization mechanism as given in 
Scheme 1. Because the number-average molecular weights calculated from the 
amino group analysis (one amino group to one oligo-St) were approximately 
the same as those determined by HPLC or VPO, as shown in Table I, it was 
confirmed that, on the average, one terminal amino group was present per 
oligo-St chain. The molecular weights of PSt-NH, [l] can be easily controlled 
by varying the amounts of AESH.'43'8 This is due to the large chain transfer 
constant, C, of AESH as calculated from the slope of the relation be&een 
l/Pn and AESH/St. We found C, = 1.6 while Okano and co-worker~'~ report- 
ed a C, value of 1.0. Ikada and co-workers'8 showed that no appreciable chain 
transfer reaction took place when methyl methacrylate was polymerized using 
AESH as chain transfer agent. 
'H-NMR spectra (phenyl groups: 6.5-7.0 ppm and PSt backbone: 1.4-2.0 
ppm) and IR spectra (N-H stretch: 3340 cm-' and C-N stretch: 1090 
cm-') confirmed the structure of PSt-NH, [l]. 
Synthesis of Amino-Semitelechelic Polystyrene-Poly(ethy1ene 
oxide) Diblock Copolymer [6] 
A schematic representation of the synthesis of PSt-PEO-NH, diblock 
copolymers [6] is shown in Scheme 2. PSt-N=C=O [3] was prepared by a 
reaction of PSt-NH, [l] with TDI [2], at 40°C for 120 h using a ratio of 
I + 2R' 
R' + H,NCH,CH,SH -b RH + H,NCH,CH,S' 
H,NCH,CH,S' + M -+ H,NCH,CH,SM; 
H,NCH,CH,SM; + (n-1)M + H,NCH,CH,SMi 
H,NCH,CH,SMi + HENCHaCHlSH + H,NCHaCH,SM,H + HlNCHaCH2S' 
Scheme 1. Mechanism for the free-radical oligomerization of St using AESH as chain transfer 
agent. I is initiator, M is styrene. 
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TABLE I 
Preparation and Analysis of PSt-NH, [l]" 
Molar ratio Yield 
Code AESH/St Mnb Zw/Mnb M; a n d  Mnb,c/and 
P1 0.005 21 15700 2.87 - 15900 0.99 
P2 0.010 21 11900 2.98 - 10300 1.16 
P3 0.020 9 2800 1.46 3300 3500 0.94 
"Reaction conditions: Styrene (St, 5.00 mol/L in DMF), AIBN 5 X 10W3 mol/L and 2- 
b&& and zw determined by HPLC in THF. 
'an determined by VPO in toluene at 37°C. 
'an determined by end group analysis. 
aminoethanethiol, AESH. Reaction for 16 h at 60°C. 
[NH,]/[NCO] = 0.5. The presence of isocyanate groups in the prepolymer 
was confirmed by IR spectroscopy (N=C=O stretch: 2270 cm-'). The cou- 
pling with H,N-PEO-NH, [4] was carried out at  room temperature for 72 h 
using a final [NH,]/[NCO] ratio of 2.4. As shown in Table 11, the molecular 
weights determined from the amino group analysis (one amino group to one 
molecule PSt-PEO), correlated well with the calculated molecular weights, 
except for the low molecular weight copolymer PE3. Also the compositions of 
the diblock copolymers determined from 'H-NMR spectra correlated well 
with the calculated compositions, except for the low molecular weight 
components. In this case possibly some ABA type block copolymer (calcd. St 
mo1% 85) was formed, resulting in less than one amino group per PSt-PEO 
molecule chain. 
The molecular weight distributions of the synthesized diblock copolymers 
and their precursors were determined. The HPLC plots for two diblock 
0 
141 [51 
CI 
Ri-N=C=N-Rz H 
[ 5 ]  + Hep-COOH + 
0 
[71 
Scheme 2. Schematic representation of the synthesis of polystyrenepoly(ethy1ene oxide)- 
heparin block copolymers. 
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TABLE I1 
Preparation and Analysis of PSt-PEO-NH, [6]' 
[St mol $1 Mn Yieldb 
Code PSt PEO ($1 Calcd. Found' %:/a/ 
PE1 15700 4OOO 31 62 61 - 20900 0.94 
PE2 11900 4OOO 33 56 56 - 16300 0.98 
PE3 3300 500 31 74 87 7400 6600 0.58 
'Reaction conditions: for details see experimental part. 
bYield of copolymer based on mol PSt. 
'From NMR-spectroecopy. 
'M,, determined by VPO in toluene at  37°C. 
'M,, determined by end group analysis. 
'an = M,,(PSt) + ~, , (PEO) Calculated. 
copolymers, PE1 and PE3, and the HPLC plots for their intermediate poly- 
mers (P1 and P3) are shown in Figure 1. We quantitatively determined the 
aw/Sn ratio only for the PSt blocks using available calibration curves (see 
Table I). For diblock copolymer PE1 (see Fig. l), aw, apJ'n, app 72.20, where- 
as copolymer PE3 shows a leas broader distribution with Mw,apJMn,app = 1.20. 
For all polymers, single peaks were obtained without shoulders, although some 
tailing in the lower molecular weight region can be seen. These results indicate 
that the polymerizations and subsequent coupling reactions have followed an 
uniform pattern although it cannot be deduced from the HPLC plot that 
copolymer PE3 also may contain some ABA type block copolymer. 
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'H-NMR spectra (phenyl groups: 6.5-7.0 ppm, methylene-ether PEO 
backbone: 3.4-3.8 ppm and PSt backbone: 1.4-2.0 ppm) confirmed the struc- 
ture of PSt-PEO-NH, diblock copolymers [5]. Copolymer formation was 
indicated by the disappearance of the isocyanate IR band (2270 cm-') of 
PSt-N=C=O [3] and appearance of the covalent urea linkage (-NH- 
CO-NH-: 1660 cm-') between the PSt and PEO (C-0-C stretch: 1115 
cm-') chains. 
Synthesis of Polystyrene-Poly(ethy1ene oxide)-Heparin Block 
Copolymer [7] 
PSt-PEO-Hep [7] was synthesized by a coupling reaction of 
PSt-PEO-NH, [6] with heparin [6] using EDC15 as a coupling agent in a 
DMF-H,O (40 : 1, v/v) mixture. EM= activates carboxylic groups which are 
present in heparin. These activated carboxylic groups react exclusively with 
the amino groups of the PSt-PEO-NH, [5] Al3 type block copolymers to 
yield ABC type block copolymers, shown in Table 111. It was shown that 
depending on the molecular weight and composition of the diblock copolymers 
25-29% w/w heparin was coupled. Taking into account that the Bn of this 
heparin as determined by Hennink and co-~orkers'~ is 11O00, it is possible to 
calculate the average-number of PSt-PEO chains coupled to one heparin 
molecule from the results in Table 111. It was determined that approximately 
2 PSt-PEO (PE2, = 16300) chains per heparin molecule chain and 
approximately 4 PSt-PEO (PE3, = 6900) chains per heparin molecule 
chain were coupled. 
In the coupling reaction of PSt-PEO-NH, [5] and Hep [6], heparin 
carboxylic groups are modified and consequently the heparin activity may 
change. As pointed out by Danishefsky and co-workers20 and Sederel and 
co-workers,21 modification of heparin carboxylic groups leads to a decreased 
anticoagulant activity. To neutralize thrombin activity, heparin molecules 
must contain binding regions for both AT I11 and thrombin. Thus heparin 
modification or linking may alter the formation or e x p u r e  of these binding 
sites, resulting in reduced bioactivity. As stated by Ebert and Kim,8 irrespec- 
tive of the anticoagulant mechanisms involved with immobilized heparins, the 
anticoagulant activity greatly increases as the immobilized heparin molecules 
are removed form the surface environment to a bulk-like plasma environment 
via spacer groups. The studies for these materials as being possible compounds 
for the improvement of the blood-compatibility are now under investigation. 
TABLE I11 
Preparation and Analysis of PSt-PEO-Hep [7]' 
PSt-PEO-NH, HeP EDC Yield Hep in block 
Code (9) (mg) (mg) (9) [w/w X, (s.e.m.)] 
~ 
PEHl PE1 2.03 180 66 0.62 - 
PEH2 PE2 2.63 376 132 1.19 25(*4) 
PEH3 PE3 2.53 737 264 1.37 29(&2) 
'Readion conditions: for details see experimental part. 
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CONCLUSIONS 
Polystyrene with one amino group per molecular chain was synthesized by 
free radical oligomerization of styrene in DMF, using 2-aminoethanethiol as 
chain transfer agent.13 This amino group was used in the coupling reaction 
with amino-telechelic poly(ethy1ene oxide) [4] to produce an AB type diblock 
copolymer with one amino group per PSt-PEO molecular chain. The amino- 
semitelechelic oligo-styrene [l] was converted into the isocyanate-semitele- 
chelic oligo-styrene [3] using toluene 2,rl-diisOcyanate [2] and a subsequent 
coupling with H,N-PEO-NH, [4] afforded AB type block copolymers with 
terminal amino groups. 
The coupling of heparin [6] to PSt-PEO-NH, [5] was performed in a 
DMF-H,O mixture, first by activating the heparin carboxylic groups with 
EDC1' at pH 5.1-5.2 and subsequently reacting the activated carboxylic 
group with the amino groups of the PSt-PEO-NH, [5] at pH 7.5. The yield 
of coupled heparin was 25 to 29% w/w depending on molecular weight of 
diblock copolymers. This new procedure enables the preparation of block 
copolymers composed of a hydrophobic block of polystyrene, a hydrophilic 
spacer-block of poly(ethy1ene oxide) and a bioactive block of heparin. These 
polymers will be further evaluated as possible compounds for the improve- 
ment of the blood-compatibility of polymeric surfaces. 
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